Alia Therapeutics
PrivateLast Round
Seed
Apr 17, 2023
Total Funding Raised
$6.27M
Company Overview
Alia Therapeutics operates in Healthcare & Life Sciences and is based in Trento. Its latest recorded funding round was a Seed round in April 2023.
Alia Therapeutics is a biotechnology company that develops CRISPR-based gene-editing therapies to treat inherited genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alia Therapeutics Comparables
Compare Alia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acrigen Biosciences | 80% | |
| GenEditBio | 78% | |
| Scribe Therapeutics | 78% |
For institutional investors. Book with your work email.
Alia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 17, 2023 | ||||
| Seed | Jun 29, 2021 | ||||
| Seed | Apr 8, 2019 | ||||
| Accelerator | Oct 1, 2018 |
For institutional investors. Book with your work email.
Alia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banca Profilo S.p.A. | Seed |
| Indaco Venture Partners SGR | Seed |
| Sofinnova Partners | Accelerator, Seed |
| BiovelocITA | Accelerator, Seed |
| Banor SIM | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors grew 572% MoM, reaching 1K.
- Mar 8, 2024
Grew 25% QoQ, from 12 to 15 employees.
For institutional investors. Book with your work email.
Alia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alia Therapeutics's valuation, stock price, and market status.
Is Alia Therapeutics a public or private company?
Alia Therapeutics is a private company.
What is the current stock price of Alia Therapeutics?
Alia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Alia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alia Therapeutics worth (valuation)?
Valuation information for Alia Therapeutics is not publicly available.
Can I buy Alia Therapeutics stock?
Alia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alia Therapeutics's last funding round?
Alia Therapeutics's most recent funding round was Seed on April 17, 2023.
Who are the main investors in Alia Therapeutics?
Key investors in Alia Therapeutics include Sofinnova Partners, BiovelocITA.
Will Alia Therapeutics IPO soon?
No public IPO plans have been announced for Alia Therapeutics.
How can I track Alia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Alia Therapeutics's shares on secondary markets.